Authors

  • A. Aliev
    Tashkent Pediatric Medical Institute
  • N. Akmalova
    Tashkent Pediatric Medical Institute

DOI:

https://doi.org/10.71337/inlibrary.uz.ijai.72520

Abstract

Clinical and biochemical characteristics of the course of severe pneumonia in young children were identified. Cytochemical changes were revealed.

 

 

background image

INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE

ISSN: 2692-5206, Impact Factor: 12,23

American Academic publishers, volume 05, issue 03,2025

Journal:

https://www.academicpublishers.org/journals/index.php/ijai

page 12

CHARACTERISTICS OF PERIPHERAL BLOOD MONOCYTES IN СONGETITAL

CLEFT IN YOUNG CHILDREN

Aliev A.L., Akmalova N.A.

Department of Pediatrics, Tashkent Pediatric Medical Institute

Objective:

The aim of the study is the analysis of clinical and biochemical characteristics of the

course of severe pneumonia in young children with congenital cleft.

Materials and methods:

Medical history, clinical observations, radiological, biochemical

studies.

Results:

Clinical and biochemical characteristics of the course of severe pneumonia in young

children were identified. Cytochemical changes were revealed.

Keywords:

young children, pneumonia, congenital cleft, biochemistry

Relevance:

Acute pneumonia in young children remains a significant cause of morbidity and

mortality despite the implementation of highly effective broad-spectrum antimicrobial drugs, the

presence of comprehensive supportive treatment regimens, and the availability of advanced

therapeutic approaches(2,3,4,5).
Energy deficiency, anemia, dysbiosis, atopic dermatitis, and other conditions further exacerbate

the situation(1).
Children with congenital anomalies of the tissues and organs of the maxillofacial region occupy

a special place. Great interest lies in assessing the clinical course of acute pneumonia in such

premature children. However, despite this, there is a scarcity of literature or any theoretical or

practical data that could be of significant importance for treating this group of patients.

Treatment is associated with particular difficulties, requiring the participation of highly qualified

specialists, proper sequencing, and a comprehensive approach(6,7,8).
We consider myeloperoxidase (MP), acid phosphatase (AP), and succinate dehydrogenase (SDH)

to be important indicators. Therefore, it was of interest to study the activity of SDH, MP, and AP

depending on the stage of the disease.

Materials and Methods

A total of 60 children aged 3 months to 3 years were examined. This included 30 children with

ordinary pneumonia, 30 with congenital cleft, and 20 with purulent-destructive pneumonia as a

complication of AP. The control group consisted of 22 healthy children of the same age.

In all patients, in addition to general clinical and radiological studies, the activity of MP, AP, and

SDH in peripheral blood monocytes was determined at admission, during the acute phase of the

disease, during improvement in the general condition, and upon recovery.

MP activity was determined using the methods of Goloberg and Barka, followed by the

calculation of the average cytochemical index (ACI). SDH activity was assessed using a

quantitative cytochemical method developed by R.P. Narcissov. The diagnosis of pneumonia

was made according to the ICD-10 classification (2010).

Results and Discussion


background image

INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE

ISSN: 2692-5206, Impact Factor: 12,23

American Academic publishers, volume 05, issue 03,2025

Journal:

https://www.academicpublishers.org/journals/index.php/ijai

page 13

Parents of the sick children mainly reported fever, restlessness, catarrhal symptoms, cough,

severe weakness, shortness of breath, sleep disturbances, reduced appetite, and dyspeptic

symptoms.

The semiotics of respiratory organ involvement primarily manifested as mixed dyspnea in all

patients, as well as increased resistance in the airways during exhalation in 12 children. Among

them, 16 patients exhibited particularly difficult and prolonged exhalation, indicating a

pronounced obstructive syndrome.

Impairments in external respiratory function were evidenced by nasal flaring in 30 patients and

retraction of compliant areas of the chest in 41 patients.

The frequency of various toxic and exacerbating syndromes associated with pneumonia in the

primary group was as follows:

• Obstructive syndrome: 22 cases (0.24).

• Cardiorespiratory syndrome: 5 cases (0.05).

• Dyscirculatory syndrome: 8 cases (0.1).

• Disseminated intravascular coagulation (DIC) syndrome: 2 cases (0.02).

• Exicosis (severe dehydration): 1 case (0.01).

In the comparison group, the frequency of these syndromes differed:

• Obstructive syndrome: 16 cases (0.23).

• Cardiorespiratory syndrome: 23 cases (0.32).

• Neurotoxic syndrome: 17 cases (0.03).

• Circulatory syndrome: 6 cases (0.084).

• DIC syndrome: 2 cases (0.03).

Bronchial obstruction syndrome was clinically manifested by expiratory dyspnea…

…during the course of the disease, and by the time of recovery, it exceeded the age norm by 1.5

times (P<0.001). The observed changes in MP levels can be explained by the concentration of

components of the myeloperoxidase system in the cells involved in phagocytosis.

When analyzing the data, the highest increase in AP activity was also noted in children with

rapidly progressing, destructive pneumonia. The maximum increase, compared to the control

group, was recorded during the acute phase of the disease (P<0.001). The decrease in enzyme

activity paralleled the clinical improvement, but even at the point of recovery, it remained higher

than the control values.

The assessment of SDH levels in purulent-destructive pneumonia as a complication of congenital

cleft showed a pronounced depression during the acute phase (P<0.001). There was a more rapid

increase in enzyme activity during the pathological process compared to other forms.

Discussion

The results of our research demonstrated that acute pneumonia developing as a complication is

characterized by a severe course. Cytochemical changes in peripheral blood monocytes indicate

an intense inflammatory process with acute severity. These changes highlight the impact on the

organism at multiple levels: systemic, tissue, organ, and cellular.

Based on these observations, cytochemical studies of the enzyme spectrum in blood cells,

particularly monocytes, can be used to assess the depth of metabolic disturbances and the state of

the organism’s reactivity at the cellular level.


background image

INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE

ISSN: 2692-5206, Impact Factor: 12,23

American Academic publishers, volume 05, issue 03,2025

Journal:

https://www.academicpublishers.org/journals/index.php/ijai

page 14

This provides a foundation for further studies of patients with acute atypical pneumonia and the

development of new therapeutic approaches, as well as a logical management algorithm for such

patients.

…during the course of the disease, and by the time of recovery, it exceeded the age norm by 1.5

times (P<0.001). The changes in MP levels can be explained by the concentration of cell

components in the myeloperoxidase system involved in phagocytosis.

When analyzing the data, the greatest increase in AP activity was also observed in children with

rapidly progressing destructive pneumonia. The maximum increase, compared to the control

group, was recorded during the acute phase of the disease (P<0.001). The reduction in enzyme

activity paralleled clinical improvement, but even by the time of recovery, it remained higher

than the control level.

The evaluation of SDH levels in purulent-destructive pneumonia as a complication of congenital

cleft revealed significant depression during the acute phase (P<0.001). The enzyme activity

showed a more rapid increase in the dynamics of the pathological process compared to other

forms.

The results of our studies have shown that acute pneumonia, developing as a complication, is

characterized by a severe course. Cytochemical changes in peripheral blood monocytes indicate

an inflammatory process of high intensity and acute severity, causing alterations at the organism,

tissue, organ, and cellular levels.

Based on these premises, cytochemical studies of the enzyme spectrum in blood cells,

particularly monocytes, can be used to evaluate the depth of metabolic disturbances and the

reactivity of the organism at the cellular level.

This provides a basis for further study of patients with acute atypical pneumonia, the

development of new treatment methods, and a logical approach (algorithm) for managing these

patients.

REFERENCES:

1. Veltyshev A.F., Kapustyan A.M. Problems of childhood pathology in the context of

structural and functional disorders of biological membranes. -Moscow, 1992.

2. Geppe N.A. Respiratory infections: problems and prospects // 8th Congress of Pediatricians

of Uzbekistan "Providing medical care to children during the reform of the healthcare

system of the Republic of Uzbekistan", Tashkent, 2019.

3. Tatochenko V.K. Community-acquired pneumonia in children – problems and solutions //

Russian Bulletin of Perinatology and Pediatrics. 2021; 66(1):9-21.

4. Tesyolkin E.V., Lavrenova D.S., Krivitskaya L.V. Pneumonia in children under one year of

age // International Scientific Journal "Bulletin of Science". -2023. -No.1(58). -Vol. 2. -Pp.

297-302.

5. Shamsiev F.M., Musajanova R.A., Azizova N.D., et al. Modern approaches to the treatment

of children with community-acquired pneumonia // Journal of Theoretical and Clinical

Medicine. Tashkent, 2019. -No. 6. -Pp. 84-88.


background image

INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE

ISSN: 2692-5206, Impact Factor: 12,23

American Academic publishers, volume 05, issue 03,2025

Journal:

https://www.academicpublishers.org/journals/index.php/ijai

page 15

6. Aliev A.L., Akhrorhonov R.A., Abdullaev D.B., Kuziev D.V. Some indicators of immune

status in severe pneumonia in young children due to congenital cleft lip and palate.

American Journal of Medical Sciences. 2024; 14(4): 1044-1046.

7. Karimjanov I.A., Fayzieva U.A. Genetic predisposition to out-of-hospital pneumonia in

children; a modern interpretation of the problem. The American Journal of Medical Sciences

and Pharmaceutical Research. 2021; 3(05): 51-57.

8. Razikova I.S., Razikova G.R., Aidarova N.P., Baybekova V.F., Ahmedova H.S. Prevalence

of allergic diseases among the age group 0-8 years of the population of Uzbekistan. Europe

Journal of Pharmaceutical and Medical Research. 2020; 7(3): 5-10.

References

eltyshev A.F., Kapustyan A.M. Problems of childhood pathology in the context of structural and functional disorders of biological membranes. -Moscow, 1992.

Geppe N.A. Respiratory infections: problems and prospects // 8th Congress of Pediatricians of Uzbekistan "Providing medical care to children during the reform of the healthcare system of the Republic of Uzbekistan", Tashkent, 2019.

Tatochenko V.K. Community-acquired pneumonia in children – problems and solutions // Russian Bulletin of Perinatology and Pediatrics. 2021; 66(1):9-21.

Tesyolkin E.V., Lavrenova D.S., Krivitskaya L.V. Pneumonia in children under one year of age // International Scientific Journal "Bulletin of Science". -2023. -No.1(58). -Vol. 2. -Pp. 297-302.

Shamsiev F.M., Musajanova R.A., Azizova N.D., et al. Modern approaches to the treatment of children with community-acquired pneumonia // Journal of Theoretical and Clinical Medicine. Tashkent, 2019. -No. 6. -Pp. 84-88.

Aliev A.L., Akhrorhonov R.A., Abdullaev D.B., Kuziev D.V. Some indicators of immune status in severe pneumonia in young children due to congenital cleft lip and palate. American Journal of Medical Sciences. 2024; 14(4): 1044-1046.

Karimjanov I.A., Fayzieva U.A. Genetic predisposition to out-of-hospital pneumonia in children; a modern interpretation of the problem. The American Journal of Medical Sciences and Pharmaceutical Research. 2021; 3(05): 51-57.

Razikova I.S., Razikova G.R., Aidarova N.P., Baybekova V.F., Ahmedova H.S. Prevalence of allergic diseases among the age group 0-8 years of the population of Uzbekistan. Europe Journal of Pharmaceutical and Medical Research. 2020; 7(3): 5-10.